OBJECTIVE: To describe the sleep patterns and level of fatigue in children and adolescents (6-18 years of age) with HIV infection, compared with ethnic-, gender-, and age-matched healthy children in the home setting. DESIGN: Descriptive, comparative. SETTING: Conducted in each child's home environment. STUDY PARTICIPANTS: Eighteen HIV-infected and 15 noninfected children completed the study. The Centers for Disease Control and Prevention HIV classifications for the 18 HIV-infected children were: A (n = 7), B (n = 6), and C (n = 5). METHODS: A symptom diary was developed using a previously validated fatigue assessment scale, modified for use with children. Content validity of the diary was established with a panel of 5 experts in child development and pediatric HIV disease. Children were asked to complete the diary each morning and evening for 3 days. Each child wore a wrist actigraph during the same period. RESULTS: The HIV-infected children had significantly more wake time after sleep onset, compared with noninfected children (13.55% vs 7. 47%). The HIV-infected children had more awakenings (25.33 vs 16.71) and were awake for longer periods (3.01 vs 1.01 minutes), compared with noninfected children. By parent report, 7 HIV-infected children napped and 2 noninfected children napped, indicating greater daytime fatigue in the HIV-infected children. HIV-infected children also reported a greater level of evening tiredness (2.47 vs 1.8). CONCLUSIONS: The findings from this study suggest that sleep disturbances occur in HIV-infected children, similar to findings previously described in HIV-infected adults. Additional research is necessary to characterize the nature and patterns of sleep disturbance and fatigue related to pediatric HIV-infection, to assess the impact these may have on daily activities, and to develop strategies to improve sleep for these children.
OBJECTIVE: To describe the sleep patterns and level of fatigue in children and adolescents (6-18 years of age) with HIV infection, compared with ethnic-, gender-, and age-matched healthy children in the home setting. DESIGN: Descriptive, comparative. SETTING: Conducted in each child's home environment. STUDY PARTICIPANTS: Eighteen HIV-infected and 15 noninfected children completed the study. The Centers for Disease Control and Prevention HIV classifications for the 18 HIV-infectedchildren were: A (n = 7), B (n = 6), and C (n = 5). METHODS: A symptom diary was developed using a previously validated fatigue assessment scale, modified for use with children. Content validity of the diary was established with a panel of 5 experts in child development and pediatric HIV disease. Children were asked to complete the diary each morning and evening for 3 days. Each child wore a wrist actigraph during the same period. RESULTS: The HIV-infectedchildren had significantly more wake time after sleep onset, compared with noninfected children (13.55% vs 7. 47%). The HIV-infectedchildren had more awakenings (25.33 vs 16.71) and were awake for longer periods (3.01 vs 1.01 minutes), compared with noninfected children. By parent report, 7 HIV-infectedchildren napped and 2 noninfected children napped, indicating greater daytime fatigue in the HIV-infectedchildren. HIV-infectedchildren also reported a greater level of evening tiredness (2.47 vs 1.8). CONCLUSIONS: The findings from this study suggest that sleep disturbances occur in HIV-infectedchildren, similar to findings previously described in HIV-infected adults. Additional research is necessary to characterize the nature and patterns of sleep disturbance and fatigue related to pediatric HIV-infection, to assess the impact these may have on daily activities, and to develop strategies to improve sleep for these children.
Authors: A K Nkwata; S K Zalwango; F N Kizza; J N Sekandi; J Mutanga; M Zhang; P M Musoke; A E Ezeamama Journal: Qual Life Res Date: 2017-05-22 Impact factor: 4.147
Authors: Samuel B Foster; Ming Lu; Daniel G Glaze; James M Reuben; Lynnette L Harris; Evan N Cohen; Bang-Ning Lee; Enxu Zhao; Mary E Paul; Heidi Schwarzwald; Chivon McMullen-Jackson; Charla Clark; F Daniel Armstrong; Pim Y Brouwers; Tracie L Miller; Andrew A Colin; Gwendolyn B Scott; Shahriar Shahzeidi; Elizabeth J Willen; Deshratn Asthana; Steven E Lipshultz; Bruce W Thompson; William T Shearer Journal: Clin Immunol Date: 2012-05-02 Impact factor: 3.969
Authors: Elizabeth G Ibarra-Coronado; Ana Ma Pantaleón-Martínez; Javier Velazquéz-Moctezuma; Oscar Prospéro-García; Mónica Méndez-Díaz; Mayra Pérez-Tapia; Lenin Pavón; Jorge Morales-Montor Journal: J Immunol Res Date: 2015-08-31 Impact factor: 4.818